Actively Recruiting

Phase Not Applicable
Age: 2Years - 6Years
All Genders
Healthy Volunteers
ID07056244

Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block for Pediatrics Undergoing Inguinal Hernia Surgery: A Comparative Prospective Double-Blind Randomized Clinical Trial

Led by Sohag University · Updated on 2025-08-11

80

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are comparing two drugs, dexamethasone and dexmedetomidine, to see how well they work as additions to bupivacaine in a caudal epidural block for children aged 2 to 6 years undergoing inguinal hernia surgery. This prospective, randomized, double-blind study aims to evaluate postoperative pain relief in these pediatric patients. Participants are randomly assigned to one of two groups: one group receives bupivacaine 0.125% at 0.5 ml/kg combined with dexmedetomidine 1.5 mcg/kg, and the other group receives bupivacaine 0.125% at 0.5 ml/kg combined with dexamethasone 0.2 mg/kg. These treatments are given to manage pain after surgery. During the study, pain scores will be monitored at 15-minute intervals for the first two hours after surgery, then at 4, 6, 8, 12, and 24 hours. The main outcome measured is the duration of effective postoperative pain relief. The study is sponsored by Sohag University and expects to complete by December 2025.

CONDITIONS

Brief Title

Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block

Who Can Participate

Age: 2Years - 6Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged 2 to 6 years
  • Both sexes
  • American Society of Anesthesiologists (ASA) physical status I or II
  • Scheduled for inguinal hernia surgery
Not Eligible

You will not qualify if you...

  • Parents or legal guardians refusal
  • Known hypersensitivity to any study drugs
  • Abnormal sacral anatomy
  • Local infection at the injection site
  • Neurological disease
  • Coagulopathy
  • Mental retardation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Single procedure on surgery day with monitoring up to 24 hours postoperatively

Participants receive a caudal epidural block with Bupivacaine combined with either Dexmedetomidine or Dexamethasone for postoperative pain relief after inguinal hernia surgery.

1 baseline visit (surgery day) and multiple assessments during the first 24 hours

Trial Site Locations

Total: 1 location

1

Sohag university Hospital

Sohag, Egypt

Actively Recruiting

Loading map...

Research Team

R

Reham R Younis, resident

H

Hala M Hashem, assistant professor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here